NO842631L - Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazino-pteridin-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazino-pteridin-derivater

Info

Publication number
NO842631L
NO842631L NO842631A NO842631A NO842631L NO 842631 L NO842631 L NO 842631L NO 842631 A NO842631 A NO 842631A NO 842631 A NO842631 A NO 842631A NO 842631 L NO842631 L NO 842631L
Authority
NO
Norway
Prior art keywords
piperazino
group
preparation
therapeutic active
pteridine derivatives
Prior art date
Application number
NO842631A
Other languages
English (en)
Other versions
NO160920C (no
NO160920B (no
Inventor
Josef Roch
Josef Nickl
Erich Mueller
Berthold Narr
Johannes Weisenberger
Rainer Zimmermann
Walter Haarmann
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of NO842631L publication Critical patent/NO842631L/no
Publication of NO160920B publication Critical patent/NO160920B/no
Publication of NO160920C publication Critical patent/NO160920C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO842631A 1983-07-02 1984-06-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazino-pteridin-derivater. NO160920C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833323932 DE3323932A1 (de) 1983-07-02 1983-07-02 Neue 2-piperazino-pteridine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel

Publications (3)

Publication Number Publication Date
NO842631L true NO842631L (no) 1985-01-03
NO160920B NO160920B (no) 1989-03-06
NO160920C NO160920C (no) 1989-06-14

Family

ID=6203017

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842631A NO160920C (no) 1983-07-02 1984-06-29 Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazino-pteridin-derivater.

Country Status (17)

Country Link
EP (1) EP0134922B1 (no)
JP (1) JPS6025991A (no)
AT (1) ATE39253T1 (no)
AU (1) AU565105B2 (no)
CA (1) CA1233179A (no)
DD (1) DD229990A5 (no)
DE (2) DE3323932A1 (no)
DK (1) DK159113C (no)
ES (2) ES533298A0 (no)
FI (1) FI80454C (no)
GB (1) GB2143232B (no)
HU (1) HU190932B (no)
IL (1) IL72265A (no)
NO (1) NO160920C (no)
NZ (1) NZ208725A (no)
PH (1) PH22493A (no)
ZA (1) ZA844968B (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445298A1 (de) * 1984-12-12 1986-06-12 Dr. Karl Thomae Gmbh, 7950 Biberach Neue pteridine, verfahren zu ihrer herstellung und deren verwendung als zwischenprodukte oder als arzneimittel
DE3540952C2 (de) * 1985-11-19 1997-08-14 Thomae Gmbh Dr K 2-Piperazino-pteridine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
WO2005021003A2 (en) * 2003-08-29 2005-03-10 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
US7276506B2 (en) 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
DE10202468A1 (de) * 2002-01-23 2004-09-30 Faustus Forschungs Cie. Translational Cancer Research Gmbh Pteridinderivate, Verfahren zu deren Herstellung und ihre Verwendung
GB2407089A (en) * 2003-10-17 2005-04-20 4 Aza Bioscience Nv Pteridine derivatives
DE102004057595A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057645A1 (de) * 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057594A1 (de) 2004-11-29 2006-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substitueirte Pteridine zur Behandlung von entzündlichen Erkrankungen
DE102004057618A1 (de) * 2004-11-29 2006-06-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Substituierte Pteridine zur Behandlung von entzündlichen Erkrankungen
CA2652840C (en) 2006-05-24 2014-09-09 Boehringer Ingelheim International Gmbh 2-piperazino-6-chloro-pteridines as pde4-inhibitors for the treatment of inflammatory diseases
ATE549338T1 (de) * 2006-05-24 2012-03-15 Boehringer Ingelheim Int Substituierte pteridine, die mit einem viergliedrigen heterocyclus substituiert sind
US20090318456A1 (en) * 2006-07-06 2009-12-24 Gilead Sciences, Inc. Substituted pteridines for the treatment and prevention of viral infections
US10144736B2 (en) 2006-07-20 2018-12-04 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
PL3321265T3 (pl) 2015-03-04 2020-11-16 Gilead Sciences, Inc. Związki 4,6-diamino-pirydo[3,2-d]pirymidynowe i ich wykorzystanie jako modulatorów receptorów toll-podobnych
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
SI3507276T1 (sl) 2016-09-02 2022-01-31 Gilead Sciences, Inc. Spojine modulatorja toličnih receptorjev
TW202210480A (zh) 2019-04-17 2022-03-16 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202212339A (zh) 2019-04-17 2022-04-01 美商基利科學股份有限公司 類鐸受體調節劑之固體形式
TW202115056A (zh) 2019-06-28 2021-04-16 美商基利科學股份有限公司 類鐸受體調節劑化合物的製備方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2940972A (en) * 1957-06-27 1960-06-14 Thomae Gmbh Dr K Tri-and tetra-substituted pteridine derivatives
FR1352111A (fr) * 1962-01-25 1964-02-14 Lumiere Lab Triamino ptéridines et leur préparation

Also Published As

Publication number Publication date
FI80454C (fi) 1990-06-11
ES8503352A1 (es) 1985-02-16
JPS6025991A (ja) 1985-02-08
HUT34487A (en) 1985-03-28
ES533298A0 (es) 1985-02-16
GB2143232B (en) 1986-11-05
NO160920C (no) 1989-06-14
ZA844968B (en) 1986-03-26
FI80454B (fi) 1990-02-28
ES8601205A1 (es) 1985-10-16
AU565105B2 (en) 1987-09-03
DK159113C (da) 1991-02-18
IL72265A (en) 1987-08-31
EP0134922B1 (de) 1988-12-14
FI842622A0 (fi) 1984-06-29
ES537785A0 (es) 1985-10-16
HU190932B (en) 1986-12-28
DD229990A5 (de) 1985-11-20
PH22493A (en) 1988-09-12
CA1233179A (en) 1988-02-23
ATE39253T1 (de) 1988-12-15
AU3009284A (en) 1985-01-03
GB2143232A (en) 1985-02-06
GB8416682D0 (en) 1984-08-01
EP0134922A1 (de) 1985-03-27
DE3323932A1 (de) 1985-01-10
DK316284D0 (da) 1984-06-28
DK316284A (da) 1985-01-03
DE3475620D1 (en) 1989-01-19
NO160920B (no) 1989-03-06
NZ208725A (en) 1988-10-28
IL72265A0 (en) 1984-10-31
DK159113B (da) 1990-09-03
FI842622A (fi) 1985-01-03

Similar Documents

Publication Publication Date Title
NO160920C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazino-pteridin-derivater.
NO158507C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9-halogen-7-okso-2,3-dihydro-7h-pyrido (1,2,3-de)(1,4)-benzoksazin-6-karboksylsyreforbindelser.
EP0163599A3 (en) Pyrimidopyrimidine derivatives, processes for producing them, pharmaceutical compositions containing them and their use as anti-allergic agents
DE3061424D1 (en) 8-phenyl purines, their preparation and medicaments containing them
NO890440D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater.
NO161620C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 8-alkyltio-2-piperazino-pyrimido(5,4-d)pyrimidin-derivater.
NO871575L (no) Fremgangsmaate for fremstilling av 1,5-benztiazepin-derivater.
ES8403129A1 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas.
HUT43586A (en) Process for production of derivatives and salts of 8-tiotetrahydro-quinoline and medical preparatives containing thereof as active substance
SE8603589D0 (sv) Metylendioxifenantren- och stilbenderivat
ZA891108B (en) Basic-substituted 5-halo-thienoisothiazol-3(2h)-one 1,1-dioxides,a process for the preparation thereof,and pharmaceutical preparations containing these compounds
ZA881383B (en) 2-(2,3-dihydro-2-oxo-3-benzofuranyl)acetic acid derivatives,processes for preparing them and the pharmaceutical compositions which contain them
ATE75468T1 (de) Substituierte 3-aminosydnonimine, verfahren zu ihrer herstellung und ihre verwendung.
AU1234588A (en) New acetamides derived from 2,3-dihydro-3-phenyl-2-benzofuranone, processes for preparing them and the pharmaceutical compositions which contain them
ES485333A1 (es) Procedimiento para preparar derivados 5,6,7,8-tetrahidro-4 (3h)-quinazolinonicos y sus sales
JPS5430161A (en) 2-aminomethylbenzoxazoles and their pharmaceutically acceptable acid salts
FI934016A (fi) Foerfarande foer framstaellning av terapeutiskt aktiva kinolin- eller naftyridinkarboxylsyraderivat som innehaoller en spirosubstituent
ZA892312B (en) 7-(imidazol-1-yl)-1,4-dihydro-4-oxo-6,8-difluoro-1-cyclo-propylquinoline-3-carboxylic acid derivatives their preparation and their application as drugs